Next Weight Loss Drug on FDA Agenda: Contrave
July 30, 2010 – 8:42 pm
The Food and Drug Administration (FDA) began reviews this month on three new weight loss drugs. The first to be reviewed, Qnexa developed by Vivus Inc., which is a mixture of two existing drugs, an anticonvulsant (topiramate) and an amphetamine (phentermine). The drug performed well in trials with subjects losing 13 percent and 15 percent of their body weight.
read more
Find more info about Next Weight Loss Drug on FDA Agenda: Contrave photos videos pictures. read more
Related Info :
Tags: Agenda, Amphetamine, anticonvulsant, Contrave, Drug, Drug Photos, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Loss, Mixture, New Drugs, Next, Phentermine, Phentermine Drug, Photos Pictures, Topiramate, Vivus Inc, weight, Weight Loss Drug, Weight Loss Drugs
Sorry, comments for this entry are closed at this time.